Results 141 to 150 of about 895,426 (293)

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

How to design decision-support tools for primary healthcare using a human-centred design approach: the processes and experience of PHISICC in three Sub-Saharan countries. [PDF]

BMJ Glob Health
Rodriguez Franco D, Co-creation groups, Auer C, Zuske MK, Oyo-Ita A, Muloliwa A, Yapi RB, Berté S, Samba M, Garba AB, Njepuome AN, Ekpenyong N, Matsinhe G, Brown D, Krause LK, Sacarlal J, Bosch-Capblanch X.   +16 more
europepmc   +1 more source

Textile Creation

Sen'i Gakkaishi, 1998
openaire   +3 more sources

FP573SUCCESSFUL CREATION OF VASCULAR ACCESS IN ELDERLY : DOES IT DIFFER FROM YOUNGER ONES ? [PDF]

, 2018
Petar Djurić, Bojan Stopić, Zeljko Davidovic, Jovana Todorović, Nada Dimković   +4 more
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

The use of genetic resources in rose breeding and creation of new rose cultivars through hybridization and selection

Gabriela Roman, L. Lehel, Alpar Peter Somsai, Roxana L. STOIAN-DOD, Cătălina Dan, Claudiu Ioan Bunea, Adriana F. Sestraş, Radu E. SESTRAȘ   +7 more
openalex   +2 more sources

CREATION OF A SUSTAINABLE BRAND AND SUPPORTING MARKETING IN THE ACTIVITIES OF A TOURISM ENTERPRISE

, 2021
I. M. Pazemov
openalex   +2 more sources

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source

Ethical challenges, responses and reasoning in co-creation for health promotion: a scoping review. [PDF]

BMC Med Ethics
Chrifou R, Focquaert F, Banks S, Raus K, Longworth GR, Loisel Q, de Boer J, Koobasi M, Ghaly M, Chastin S, Altenburg T, Deforche B, Verloigne M.   +12 more
europepmc   +1 more source

TREX1, a predator for treating MSI‐H tumors?

Molecular Oncology, EarlyView.
Immunotherapy benefits many patients; yet, some with MSI‐H tumors remain unresponsive despite their high immunogenicity. Xu et al. reveal that TREX1 enables immune evasion by degrading cytosolic DNA and suppressing cGAS–STING–IFN‐I signaling. TREX1 loss restores DNA sensing, increases CD8+ T and NK cell infiltration, and boosts antitumor immunity ...
Elena Benidovskaya, Joséphine Deneft, Marc Van den Eynde   +2 more
wiley   +1 more source